Ikena Oncology, Inc.IKNANASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank96
3Y CAGR+80.8%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+80.8%/yr
Quarterly compound
Percentile
P96
Near historical high
vs 3Y Ago
5.9x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 91.30% |
| Q3 2025 | -203.93% |
| Q2 2025 | 18.94% |
| Q1 2025 | 13.77% |
| Q4 2024 | -0.89% |
| Q3 2024 | 21.59% |
| Q2 2024 | -1.14% |
| Q1 2024 | 28.59% |
| Q4 2023 | -12.33% |
| Q3 2023 | -5.48% |
| Q2 2023 | -19.17% |
| Q1 2023 | -2.65% |
| Q4 2022 | 15.45% |
| Q3 2022 | 14.68% |
| Q2 2022 | -23.52% |
| Q1 2022 | -707.52% |
| Q4 2021 | 119.23% |
| Q3 2021 | -14.46% |
| Q2 2021 | -30.52% |
| Q1 2021 | 62.69% |
| Q4 2020 | -317.98% |
| Q3 2020 | -23.21% |
| Q2 2020 | 29.50% |
| Q1 2020 | -31.84% |
| Q4 2019 | 0.00% |